HB3637 - 104th General Assembly
HEALTH REGULATION-VARIOUS
House Sponsors
Rep. Dagmara Avelar - Kelly M. Cassidy - Jehan Gordon-Booth - Robyn Gabel - Bob Morgan, Joyce Mason, Nabeela Syed, Abdelnasser Rashid, Aarón M. Ortíz, Edgar González, Jr., Barbara Hernandez, Nicolle Grasse, Anna Moeller, Lindsey LaPointe, Margaret Croke, Eva-Dina Delgado, Kimberly Du Buclet, Yolonda Morris, Jennifer Gong-Gershowitz, Sharon Chung, Will Guzzardi, Mary Beth Canty, Michael Crawford, Maura Hirschauer, Janet Yang Rohr, Natalie A. Manley, Camille Y. Lilly, Amy Briel, Michelle Mussman and Laura Faver Dias
Senate Sponsors
(Sen. Karina Villa, Sara Feigenholtz, Omar Aquino, Mike Simmons, Mary Edly-Allen, Rachel Ventura, Graciela Guzmán and Paul Faraci)
Statutes Amended In Order of Appearance
225 ILCS 15/15from Ch. 111, par. 5365
225 ILCS 55/85from Ch. 111, par. 8351-85
225 ILCS 60/22from Ch. 111, par. 4400-22
225 ILCS 60/23from Ch. 111, par. 4400-23
225 ILCS 65/65-65was 225 ILCS 65/15-55
225 ILCS 65/70-5was 225 ILCS 65/10-45
225 ILCS 85/30from Ch. 111, par. 4150
225 ILCS 95/21from Ch. 111, par. 4621
225 ILCS 120/55from Ch. 111, par. 8301-55
410 ILCS 620/7from Ch. 56 1/2, par. 507
410 ILCS 620/14from Ch. 56 1/2, par. 514
410 ILCS 620/15from Ch. 56 1/2, par. 515
Synopsis As Introduced
Amends the Behavior Analyst Licensing Act, the Clinical Psychologist Licensing Act, the Clinical Social Work and Social Work Practice Act, the Marriage and Family Therapy Licensing Act, the Medical Practice Act of 1987, the Licensed Certified Professional Midwife Practice Act, the Nurse Practice Act, the Pharmacy Practice Act, the Physician Assistant Practice Act of 1987, the Professional Counselor and Clinical Professional Counselor Licensing and Practice Act, the Wholesale Drug Distribution Licensing Act, the Registered Surgical Assistant and Registered Surgical Technologist Title Protection Act, and the Genetic Counselor Licensing Act. Provides that the Department of Professional and Financial Regulation shall not take any disciplinary or non-disciplinary action against a person's authorization to practice (rather than against the license or permit issued) under each of the amended Acts based solely upon the person's involvement in any health care service, so long as the care was not unlawful under the laws of the State. Prohibits the Department from taking any disciplinary or non-disciplinary action against a person's authorization to practice (rather than against the license or permit issued) under each of the amended Acts based upon the person's license, registration, or permit (rather than only license) being revoked or suspended, or the person being otherwise disciplined by any other state, if that form of discipline was based solely on the person violating another state's laws prohibiting involvement in any health care service if that health care service would not have been unlawful under the laws of the State and is consistent with the applicable standard of conduct for a person practicing in Illinois under those Acts. Changes certain references to official occupation titles in the amended Acts to "person". Amends the Illinois Food, Drug and Cosmetic Act. Provides that a drug's status as not approved by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug if its safety and efficacy have been established by peer-reviewed research or if it is recommended for use by the World Health Organization, even if the drug's labelling reflects prior approval that is no longer in effect, so long as such labelling was true and accurate at the time of manufacture.
House Floor Amendment No. 1
Provides that a drug's status as not approved by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug in violation of the Act if it is recommended for use by the World Health Organization (rather than if its safety and efficacy have been established by peer-reviewed research or if it is recommended for use by the World Health Organization).
Senate Committee Amendment No. 1
Provides that, if a drug had been approved by the U.S. Food and Drug Administration before January 1, 2025, the revocation of approval by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug in violation of the Illinois Food, Drug and Cosmetic Act if the drug is recommended for use by the World Health Organization, even if the drug's labeling reflects prior approval that is no longer in effect, so long as the drug's labeling was true and accurate at the time of its manufacture. Provides that those provisions are inoperative on and after January 1, 2035.
Actions
| Date | Chamber | Action |
|---|---|---|
| 2/07/2025 | House | Filed with the Clerk by Rep. Dagmara Avelar |
| 2/18/2025 | House | First Reading |
| 2/18/2025 | House | Referred to Rules Committee |
| 3/11/2025 | House | Assigned to Health Care Availability & Accessibility Committee |
| 3/13/2025 | House | Added Co-Sponsor Rep. Joyce Mason |
| 3/13/2025 | House | Added Co-Sponsor Rep. Nabeela Syed |
| 3/13/2025 | House | Added Co-Sponsor Rep. Abdelnasser Rashid |
| 3/13/2025 | House | Added Co-Sponsor Rep. Aarón M. Ortíz |
| 3/13/2025 | House | Added Co-Sponsor Rep. Edgar González, Jr. |
| 3/13/2025 | House | Added Co-Sponsor Rep. Barbara Hernandez |
| 3/18/2025 | House | Added Co-Sponsor Rep. Nicolle Grasse |
| 3/18/2025 | House | Added Co-Sponsor Rep. Anna Moeller |
| 3/18/2025 | House | Added Co-Sponsor Rep. Lindsey LaPointe |
| 3/18/2025 | House | Added Co-Sponsor Rep. Margaret Croke |
| 3/18/2025 | House | Added Co-Sponsor Rep. Eva-Dina Delgado |
| 3/18/2025 | House | Added Co-Sponsor Rep. Kimberly Du Buclet |
| 3/18/2025 | House | Added Co-Sponsor Rep. Yolonda Morris |
| 3/18/2025 | House | Added Co-Sponsor Rep. Jennifer Gong-Gershowitz |
| 3/18/2025 | House | Added Co-Sponsor Rep. Sharon Chung |
| 3/18/2025 | House | Added Co-Sponsor Rep. Will Guzzardi |
| 3/18/2025 | House | Added Co-Sponsor Rep. Mary Beth Canty |
| 3/18/2025 | House | Added Chief Co-Sponsor Rep. Kelly M. Cassidy |
| 3/18/2025 | House | Added Chief Co-Sponsor Rep. Jehan Gordon-Booth |
| 3/18/2025 | House | Added Chief Co-Sponsor Rep. Robyn Gabel |
| 3/18/2025 | House | Added Chief Co-Sponsor Rep. Bob Morgan |
| 3/18/2025 | House | Do Pass / Short Debate Health Care Availability & Accessibility Committee; 009-005-000 |
| 3/19/2025 | House | Added Co-Sponsor Rep. Michael Crawford |
| 3/19/2025 | House | Placed on Calendar 2nd Reading - Short Debate |
| 3/19/2025 | House | House Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar |
| 3/19/2025 | House | House Floor Amendment No. 1 Referred to Rules Committee |
| 3/20/2025 | House | House Floor Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee |
| 3/25/2025 | House | House Floor Amendment No. 1 Recommends Be Adopted Health Care Availability & Accessibility Committee; 008-003-000 |
| 3/26/2025 | House | Second Reading - Short Debate |
| 3/26/2025 | House | Held on Calendar Order of Second Reading - Short Debate |
| 4/07/2025 | House | House Floor Amendment No. 1 Adopted by Voice Vote |
| 4/07/2025 | House | Placed on Calendar Order of 3rd Reading - Short Debate |
| 4/07/2025 | House | Added Co-Sponsor Rep. Maura Hirschauer |
| 4/07/2025 | House | Added Co-Sponsor Rep. Janet Yang Rohr |
| 4/07/2025 | House | Third Reading - Short Debate - Passed 067-039-000 |
| 4/07/2025 | House | Added Co-Sponsor Rep. Natalie A. Manley |
| 4/08/2025 | Senate | Arrive in Senate |
| 4/08/2025 | Senate | Placed on Calendar Order of First Reading |
| 4/08/2025 | Senate | Chief Senate Sponsor Sen. Karina Villa |
| 4/08/2025 | Senate | First Reading |
| 4/08/2025 | Senate | Referred to Assignments |
| 4/23/2025 | Senate | Assigned to Executive |
| 4/30/2025 | Senate | Added as Alternate Co-Sponsor Sen. Sara Feigenholtz |
| 5/02/2025 | Senate | Senate Committee Amendment No. 1 Filed with Secretary by Sen. Karina Villa |
| 5/02/2025 | Senate | Senate Committee Amendment No. 1 Referred to Assignments |
| 5/06/2025 | Senate | Senate Committee Amendment No. 1 Assignments Refers to Executive |
| 5/09/2025 | Senate | Rule 2-10 Committee Deadline Established As May 23, 2025 |
| 5/14/2025 | Senate | Added as Alternate Co-Sponsor Sen. Omar Aquino |
| 5/14/2025 | Senate | Senate Committee Amendment No. 1 Adopted |
| 5/15/2025 | Senate | Do Pass as Amended Executive; 008-004-000 |
| 5/15/2025 | Senate | Placed on Calendar Order of 2nd Reading |
| 5/15/2025 | Senate | Second Reading |
| 5/15/2025 | Senate | Placed on Calendar Order of 3rd Reading May 20, 2025 |
| 5/16/2025 | Senate | Added as Alternate Co-Sponsor Sen. Mike Simmons |
| 5/20/2025 | Senate | Added as Alternate Co-Sponsor Sen. Mary Edly-Allen |
| 5/21/2025 | Senate | Added as Alternate Co-Sponsor Sen. Rachel Ventura |
| 5/22/2025 | Senate | Third Reading - Passed; 038-019-000 |
| 5/23/2025 | House | Arrived in House |
| 5/23/2025 | House | Placed on Calendar Order of Concurrence Senate Amendment(s) 1 |
| 5/23/2025 | House | Senate Committee Amendment No. 1 Motion Filed Concur Rep. Dagmara Avelar |
| 5/23/2025 | House | Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee |
| 5/27/2025 | Senate | Added as Alternate Co-Sponsor Sen. Graciela Guzmán |
| 5/28/2025 | House | Senate Committee Amendment No. 1 Motion to Concur Rules Referred to Health Care Availability & Accessibility Committee |
| 5/29/2025 | House | Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Health Care Availability & Accessibility Committee; 008-004-000 |
| 5/29/2025 | House | Added Co-Sponsor Rep. Camille Y. Lilly |
| 5/30/2025 | House | Chair Rules placed on Standard debate. |
| 5/30/2025 | House | Added Co-Sponsor Rep. Amy Briel |
| 5/30/2025 | House | Added Co-Sponsor Rep. Michelle Mussman |
| 5/30/2025 | House | Added Co-Sponsor Rep. Laura Faver Dias |
| 5/30/2025 | House | Senate Committee Amendment No. 1 House Concurs 075-039-000 |
| 5/30/2025 | House | House Concurs |
| 5/30/2025 | House | Passed Both Houses |
| 6/24/2025 | House | Sent to the Governor |
| 8/20/2025 | Senate | Added as Alternate Co-Sponsor Sen. Paul Faraci |
| 8/22/2025 | House | Governor Approved |
| 8/22/2025 | House | Effective Date January 1, 2026 |
| 8/22/2025 | House | Public Act . . . . . . . . . 104-0432 |